metricas
covid
Clinics
Journal Information
Issue
portada-S1807593225X00028Vol. 81. (In progress)
(January - December 2026)
This issue is in progress but contains articles that are final and fully citable.
Original articles
The role of SIGLEC9 in immunosuppression and prognosis in cervical cancer
Bihui Wang, Yuejie Zhu, Zhenyu Ru, Yulian Zhang, Mingkai Yu, Pingfen Li, Manli Zhang, Jianbing Ding, Zhifang Chen
Clinics. 2026;81C:100849
Highlights

  • SIGLEC9 is highly expressed in cervical cancer and linked to poor prognosis.

  • Bioinformatics show SIGLEC9 correlates with macrophages and T-cells.

  • SIGLEC9+ TAMs and T-cells are highly enriched in the cervical cancer microenvironment.

  • High SIGLEC9+ TAM expression correlates with poor prognosis in cervical cancer.

Full text access
Electrophysiological evaluation of the auditory pathway in newborns and infants with peri-intraventricular hemorrhage and/or periventricular leukomalacia
Rosanna Giaffredo Angrisani, Natalia Olival Balzarini, Carla Regina Tragante, Valdenise Martins Laurindo Tuma Calil, Werther Brunow de Carvalho, Carla Gentile Matas
Clinics. 2026;81C:100853
Highlights

  • Prematurity is a risk factor for lifelong hearing damage.

  • Hearing monitoring is necessary until around 3-years of age.

  • Hearing monitoring after peri-intraventricular hemorrhage is essential.

Full text access